Delivery Order SPE2DB20D1100-SPE2DB25FC0U8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,453.72 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen injectors in 0.5 ml doses. This firm fixed-price contract, with an ultimate completion date of April 22, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $16,507.77 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on July 2, 2025, with a completion date of July 3, 2025. The contract employs firm fixed pricing and was competitively awarded with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,292.56 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of August 19, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under an open procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under...
- The Defense Logistics Agency awarded a $3,798.79 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injectors with a ceiling value of $2,287.74. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 26, 2025, and no set-aside designation. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors at a ceiling value of $7,651.06. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract is set for ultimate completion by December 9, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,275.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections (0.5 mL). The contract, which is classified as a non-set-aside competitive award, is scheduled for completion by November 26, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,845.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL), with an ultimate completion date of November 5, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $23,596.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injectors (0.5 mL). The contract, with an ultimate completion date of May 14, 2025, represents a non-set-aside, competitively awarded procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,921.52 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, designated as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC0U8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. The contract utilizes firm fixed pricing with no set-aside designation and is expected to be completed by May 5, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company's extensive federal contract portfolio with DLA includes delivery orders spanning diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded without set-aside restrictions, demonstrating the company's capability to meet federal procurement requirements. The Zepbound delivery supports military healthcare systems and aligns with DLA's pharmaceutical supply chain operations across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 5/2/25 |